By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.
AbbVie, a global research biopharmaceutical company, and R-Pharm Group announced the completion of technology transfer for manufacturing Kaletra intended for treatment of HIV/AIDS infection in adult patients.
ABISS, the French company, a manufacturer of implants, together with the Federal Corporation for the Development of Small and Medium Enterprises, prepared a "road map" for manufacturing localization of its products in Russia.
Bayer intends to raise the share of its localized products in Russia to 30% of the total sales. The company is already implementing a number of large-scale projects to localize the manufacturing of innovative medicines
Abbott presented a new production line to localize the full-cycle manufacturing of an Abbott drug to support women's reproductive health, which is in line with the strategic objectives of the government in Russia.
Offset agreements are a new effective mechanism for public procurement, in which the supplier agrees to establish or upgrade a production facility within the city, while the city authorities agree to purchase the products.
A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.
Takeda, a pharmaceutical company, has developed an innovative sugar-lowering drug that is a combination of alogliptin and metformin. The representatives of the company announced that the drug was launched in the Russian market.